Research Output per year
Fingerprint Dive into the research topics where T. Masszi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Multiple Myeloma
Medicine & Life Sciences
Stem Cell Transplantation
Medicine & Life Sciences
Bone Marrow Transplantation
Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation
Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Dexamethasone
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1991 2019
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor
Sureda, A., Chabannon, C., Masszi, T., Pohlreich, D., Scheid, C., Thieblemont, C., Wahlin, B. E., Sakellari, I., Russell, N., Janikova, A., Dabrowska-Iwanicka, A., Touzeau, C., Esquirol, A., Jantunen, E., van der Werf, S., Bosman, P., Boumendil, A., Liu, Q., Celanovic, M., Montoto, S. & 1 others, , Jan 1 2019, (Accepted/In press) In : Bone Marrow Transplantation.Research output: Contribution to journal › Article
Granulocyte Colony-Stimulating Factor
Registries
Lymphoma
Transplantation
Bone Marrow
1
Citation
(Scopus)
Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms
Mózes, R., Gángó, A., Sulák, A., Vida, L., Reiniger, L., Timár, B., Krenács, T., Alizadeh, H., Masszi, T., Gaál-Weisinger, J., Demeter, J., Csomor, J., Matolcsy, A., Kajtár, B. & Bödör, C., Jan 1 2019, (Accepted/In press) In : Pathology.Research output: Contribution to journal › Article
Calreticulin
Immunohistochemistry
Mutation
Neoplasms
Essential Thrombocythemia
1
Citation
(Scopus)
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning
Tordai, A., Bors, A., Kiss, K. P., Balassa, K., Andrikovics, H., Batai, A., Szilvasi, A., Rajczy, K., Inotai, D., Torbagyi, E., Lengyel, L., Barta, A., Remenyi, P. & Masszi, T., Jan 1 2019, In : PloS one. 14, 6, e0218945.Research output: Contribution to journal › Article
Open Access
Transplants
Hematologic Neoplasms
Stem cells
cell transplantation
Tissue Donors